Discovery and Optimization of Triazolopyrimidinone Derivatives as Selective NLRP3 Inflammasome Inhibitors

David Harrison(University of Notre Dame), Alan P. Watt(Chelmsford and Essex Hospital), Jane Scanlon(Chelmsford and Essex Hospital), Iain Simpson(Charles River Laboratories (United Kingdom)), Grant Wishart(Charles River Laboratories (United Kingdom)), Christopher A. Gabel(University of North Carolina at Chapel Hill), John R. Doedens, Pamela J. Smolak(University of North Carolina at Chapel Hill), Arwel Lewis(Charles River Laboratories (United Kingdom)), M. Katharine Holloway, Mark G. Bock, Andrew Sharpe(National Research Council Canada)
ACS Medicinal Chemistry Letters
August 1, 2022
Cited by 23


Related Papers